Ticker LaunchReverse merger · Completed · HSTO
Histogen Inc.
Reverse merger with Conatus Pharmaceuticals Inc.
Histogen Inc. merged into Conatus Pharmaceuticals Inc., a Nasdaq-listed biopharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Jan 28, 2020 and closed on May 26, 2020. The combined company trades as Histogen Inc. (HSTO) on Nasdaq.
Histogen Inc. is a regenerative medicine company developing patented technologies that replace and regenerate tissues in the body for aesthetic and therapeutic markets.
- Status
- Completed
- Private company
- Histogen Inc.
- Public company
- Conatus Pharmaceuticals Inc.
- Public company business before
- Nasdaq-listed biopharmaceutical company
- Announced
- Jan 28, 2020
- Closed
- May 26, 2020
- Combined company
- Histogen Inc. (HSTO)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K May 27, 2020
- Closing press release / exhibit
- All filings on EDGAR CIK 1383701
Other completed reverse mergers
- Blockgration Global Corp.into Zoompass Holdings, Inc. · May 31, 2020
- AYRO, Inc. (AYRO Operating Company)into DropCar, Inc. · May 28, 2020
- Chondrial Therapeutics, Inc.into Zafgen, Inc. · May 28, 2020
- GSL Healthcare, Inc.into Agentix Corp. · May 28, 2020
- Qualigen, Inc.into Ritter Pharmaceuticals, Inc. · May 22, 2020
- Forta Financial Group, Inc.into Financial Gravity Companies, Inc. · May 21, 2020